The Lancet3d
A step towards more physiological glucocorticoid dosing in congenital adrenal hyperplasia
On Dec 12, 2024, the US Food and Drug Administration (FDA) approved crinecerfont for adults and paediatric patients with ...
Compound mimics cannabis for pain relief without the side effects: Mouse study points to effective opioid alternative
Treatment for chronic pain still relies heavily on opioids. While effective, they are highly addictive and potentially deadly ...